Criterion-learning Based Naming Treatment in Aphasia
Launched by ALBERT EINSTEIN HEALTHCARE NETWORK · Apr 10, 2024
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study examines a retrieval practice-based naming treatment termed criterion learning. In criterion learning, each item's assigned criterion level dictates the number of times that item is correctly retrieved before it is dropped from further training within a session. Criterion learning optimally incorporates potent learning experiences, including spaced retrieval practice with emphasis on correct retrievals during training. By examining scheduling and dosing parameters, and feasibility of at-home delivery, the present study will provide critical observations for optimizing criterion l...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English as a native or primary language
- • Adults with stroke who are at least 6 months post-onset
- Exclusion Criteria:
- • History of comorbid neurological diagnoses, such as Multiple Sclerosis or Parkinson's Disease
- • History of a learning disability that significantly impacted language development, such as developmental language disorder
About Albert Einstein Healthcare Network
Albert Einstein Healthcare Network is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and patient care. With a commitment to excellence, the network integrates cutting-edge medical research, education, and community health initiatives to improve patient outcomes. As a sponsor of clinical trials, Albert Einstein Healthcare Network focuses on a broad range of therapeutic areas, leveraging its rich legacy of scientific inquiry and collaboration with esteemed research institutions. The network prioritizes patient safety, ethical standards, and rigorous scientific methodologies in all its clinical research endeavors, aiming to contribute meaningful advancements to the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Elkins Park, Pennsylvania, United States
Patients applied
Trial Officials
Erica L Middleton, PhD
Principal Investigator
Albert Einstein Healthcare Network
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported